Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Kovsie students selected for prestigious study travel programme
2013-05-15

 

Golden Key International Honour Society members, Michael van Niekerk, Siobhan Canavan, Mpoi Makhetha and Cebolenkosi Sokhela, will travel to the USA and China, meeting the best in their career fields.
Photo: Hannes Pieterse
15 May 2013


They are amongst the top 15 percent of academic achievers at the university, and have been afforded the opportunity to travel abroad and meet with leading people in their fields of study.

Kovsie students Michael van Niekerk, Siobhan Canavan, Mpoi Makhetha and Cebolenkosi Sokhela, all members of the Golden Key International Honour Society, will travel to the USA and China. This trip is part of the International Scholar Laureate Program (ISLP) to learn how their career fields are practiced in another part of the world. The students are part of a select group of outstanding university students from across the world who will be given access to people, places and global perspectives in fields such as business, engineering, medicine, nursing, diplomacy and international relations.

Michael, a fourth-year MBChB student and SRC member of our Bloemfontein Campus, and Cebolenkosi, a third-year BSc Microbiology student will visit Washington, Philadelphia and New York in the USA. As part of the medicine delegation of the programme, they will visit clinics and hospitals to see how their study fields are practiced. Michael’s trip includes a visit to Johns Hopkins University in Baltimore, where he will meet representatives of the National Institute of Health, the largest source of funding for medical research in the world. He will also visit Harvard University in Massachusetts.

Mpoi, a third-year BSc Human Molecular Biology student, also forms part of the medicine delegation but will travel to China. "We will be exploring the ancient ways of healing versus the modern medical practices, exploring the medical systems of the country and meeting doctors and professors, visiting the rural areas, and of course, touring the best parts of China,” she said.

Siobhan, a third-year Media Studies and Journalism student, is part of the diplomacy and international relations delegation who will visit Beijing, Xi'an and Shanghai in China. "To me it's such an honour to be part of this programme,” she said. “It will give me the platform to not only represent who I am, but also my university and the values that the university has instilled in me. It allows me to be a part of something great that will benefit me in the end."

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept